Cargando…

Simultaneous integrated dose reduction intensity-modulated radiotherapy effectively reduces cardiac toxicity in limited-stage small cell lung cancer

OBJECTIVE: To assess the clinical outcomes and toxicities of once daily (QD) simultaneous dose reduction intensity-modulated radiotherapy (SDR-IMRT-QD; SDR-QD) versus conventional QD IMRT (C-QD) and twice daily (BID) IMRT in patients with limited-stage small cell lung cancer (LS-SCLC). METHODS: Afte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Jing, Song, Jiawei, Xiao, Li, Zhang, Jiajia, Cao, Yipeng, Wang, Jun, Wang, Ping, Zhao, Lujun, Liu, Ningbo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Compuscript 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291981/ https://www.ncbi.nlm.nih.gov/pubmed/37300284 http://dx.doi.org/10.20892/j.issn.2095-3941.2022.0326

Ejemplares similares

Simultaneous integrated dose reduction intensity-modulated radiotherapy applied to an elective nodal area of limited-stage small-cell lung cancer
por: LIU, ZHIYAN, et al.
Publicado: (2015)

The efficacy and safety of simultaneous integrated dose reduction in clinical target volume with intensity-modulated radiotherapy for patients with locally advanced esophageal squamous cell carcinoma
por: Zhao, Jingjing, et al.
Publicado: (2020)

Preliminary Results about Application of Intensity-Modulated Radiotherapy to Reduce Prophylactic Radiation Dose in Limited-Stage Small Cell Lung Cancer
por: Liu, Zhiyan, et al.
Publicado: (2018)

Does the response to induction chemotherapy impact the timing of thoracic radiotherapy for limited-stage small-cell lung cancer?
por: Wang, Peng, et al.
Publicado: (2015)

The Addition of Peripheral Blood Inflammatory Indexes to Nomogram Improves the Predictive Accuracy of Survival in Limited-Stage Small Cell Lung Cancer Patients
por: Qi, Jing, et al.
Publicado: (2021)

Dose Reduction to the Scalp with Hippocampal Sparing Is Achievable with Intensity Modulated Radiotherapy
por: Witek, Matthew, et al.
Publicado: (2014)

One Cycle of Concurrent Chemotherapy vs. Two Cycles of Concurrent Chemotherapy With Radiation Therapy in Patients With Limited-Stage Small Cell Lung Cancer
por: Yu, Hao, et al.
Publicado: (2022)

Practice Patterns of Treatment Strategy of Limited-Stage Small-Cell Lung Cancer: Survey of Chinese Oncologists
por: Xu, Chang, et al.
Publicado: (2022)

Optimal dose limitation strategy for bone marrow sparing in intensity-modulated radiotherapy of cervical cancer
por: Bao, Zhirong, et al.
Publicado: (2019)

Doses of intensity-modulated radiotherapy and its association with cardiac disease in esophageal cancer patients
por: Zhang, Jiandong, et al.
Publicado: (2021)

Intensity-modulated radiotherapy reduces gastrointestinal toxicity in pelvic radiation therapy with moderate dose
por: Kwak, Yoo-Kang, et al.
Publicado: (2017)

Low radiotherapy dose is suitable for brain metastases in SCLC compared with high dose
por: Xu, Liming, et al.
Publicado: (2023)

Pretreatment prognostic factors of survival and late toxicities for patients with nasopharyngeal carcinoma treated by simultaneous integrated boost intensity-modulated radiotherapy
por: Lin, Yun-Hsuan, et al.
Publicado: (2018)

Comparison of efficacy and safety between simultaneous integrated boost intensity-modulated radiotherapy and standard-dose intensity-modulated radiotherapy in locally advanced esophageal squamous cell carcinoma: a retrospective study
por: Lan, Wang, et al.
Publicado: (2022)

Timing of thoracic radiotherapy in the treatment of extensive-stage small-cell lung cancer: important or not?
por: Luo, Jing, et al.
Publicado: (2017)

Outcome of dose-escalated intensity-modulated radiotherapy for limited disease small cell lung cancer
por: Yang, Eunyeong, et al.
Publicado: (2023)

Halofuginone inhibits radiotherapy-induced epithelial-mesenchymal transition in lung cancer
por: Chen, Yang, et al.
Publicado: (2016)

Simultaneous or staged operation for tandem spinal stenosis: surgical strategy and efficacy comparison
por: Cao, Junming, et al.
Publicado: (2021)

Long-term outcome and late toxicities of simultaneous integrated boost-intensity modulated radiotherapy in pediatric and adolescent nasopharyngeal carcinoma
por: Tao, Chang-Juan, et al.
Publicado: (2013)

MTHFR variant is associated with high-dose methotrexate-induced toxicity in the Chinese osteosarcoma patients
por: Xu, Leilei, et al.
Publicado: (2018)

Correction: Halofuginone inhibits radiotherapy-induced epithelial-mesenchymal transition in lung cancer
por: Chen, Yang, et al.
Publicado: (2018)

Dose-Escalated Hypofractionated Intensity-Modulated Radiotherapy in High-Risk Carcinoma of the Prostate: Outcome and Late Toxicity
por: Thomson, David, et al.
Publicado: (2012)

Breast Size and Dose to Cardiac Substructures in Adjuvant Three-dimensional Conformal Radiotherapy Compared to Tangential Intensity Modulated Radiotherapy
por: Ratosa, Ivica, et al.
Publicado: (2020)

Acute toxicity of normofractionated intensity modulated radiotherapy with simultaneous integrated boost compared to three-dimensional conformal radiotherapy with sequential boost in the adjuvant treatment of breast cancer
por: Krug, David, et al.
Publicado: (2020)

Dose reduction to normal tissues as compared to the gross tumor by using intensity modulated radiotherapy in thoracic malignancies
por: Kataria, Tejinder, et al.
Publicado: (2006)

Intensity-modulated radiotherapy with simultaneous integrated boost for locoregionally advanced nasopharyngeal carcinoma
por: Yi, Junlin, et al.
Publicado: (2014)

Intensity modulated radiotherapy: advantages, limitations and future developments
por: Cheung, KY
Publicado: (2006)

Cardiac Dose Reduction with Deep-Inspiratory Breath Hold Technique of Radiotherapy for Left-Sided Breast Cancer
por: Sripathi, Lalitha Kameshwari, et al.
Publicado: (2017)

Comparison of long-term survival and toxicity of simultaneous integrated boost vs conventional fractionation with intensity-modulated radiotherapy for the treatment of nasopharyngeal carcinoma
por: Tao, Hengmin, et al.
Publicado: (2016)

Dose- and Volume-Limiting Late Toxicity of FLASH Radiotherapy in Cats with Squamous Cell Carcinoma of the Nasal Planum and in Mini Pigs
por: Rohrer Bley, Carla, et al.
Publicado: (2022)

Thoracic Radiotherapy Benefits Elderly Extensive-Stage Small Cell Lung Cancer Patients with Distant Metastasis
por: Qi, Jing, et al.
Publicado: (2019)

Comparative effectiveness and toxicity of radiotherapy regimens in limited stage small cell lung cancer: A network meta‐analysis
por: Zhou, Jiupeng, et al.
Publicado: (2022)

Reduction of oesophageal toxicity with VMAT dose-sparing radiotherapy in thoracic metastatic spinal cord compression: A feasibility study
por: Gram, Vanja Remberg, et al.
Publicado: (2022)

Changes in the Dose–Response Relationship of One Toxicant Under Simultaneous Exposure to Another Toxicant
por: Katsnelson, B. A., et al.
Publicado: (2016)

Hematologic Toxicity of Conformal Radiotherapy and Intensity Modulated Radiotherapy in Prostate and Bladder Cancer Patients
por: Miszczyk, Marcin, et al.
Publicado: (2018)

Investigating rectal toxicity associated dosimetric features with deformable accumulated rectal surface dose maps for cervical cancer radiotherapy
por: Chen, Jiawei, et al.
Publicado: (2018)

Long-Term Efficacy and Toxicity of Intensity-Modulated Radiotherapy in Bulky Cervical Cancer
por: Wang, Yu, et al.
Publicado: (2023)

Short course radiotherapy with simultaneous integrated boost for stage I-II breast cancer, early toxicities of a randomized clinical trial
por: Van Parijs, Hilde, et al.
Publicado: (2012)

Dose tolerance limits and dose volume histogram evaluation for stereotactic body radiotherapy
por: Grimm, Jimm, et al.
Publicado: (2011)

Intensity modulated radiotherapy for localized prostate cancer: rigid compliance to dose-volume constraints as a warranty of acceptable toxicity?
por: Chen, Michael J, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_plghkcdtsheci6hjodovtrjlkc